Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

BACKGROUND: Brimonidine tartrate is a highly selective alpha 2 agonist that induces direct vasoconstriction of small arteries and veins, thereby reducing vasodilation and edema. OBJECTIVE: To review the current literature regarding the safety, efficacy, and patient acceptability of brimonidine 0.33%...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Patient Prefer Adherence
Auteurs principaux: Anderson, Michael S, Nadkarni, Anish, Cardwell, Leah A, Alinia, Hossein, Feldman, Steven R
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2017
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505675/
https://ncbi.nlm.nih.gov/pubmed/28740369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S115708
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires